@article{article, title  = {{Cost-effectiveness analysis of contemporary first-line (1L) agents in locally advanced/metastatic urothelial carcinoma (la/mUC).}},

 publisher = {{American Society of Clinical Oncology (ASCO)}},

 url = {{https://doi.org/10.1200/jco.2024.42.16_suppl.4591 }},

 year = {{2024}},

 month = {{5}},

 author = {{Naqvi SAA and Faisal KS and Raina A and Khakwani KZR and Riaz ZB and Shah VS and Cobran EK and Singh P and Hussain SA and Bryce AH and Riaz IB}},

 doi = {{10.1200/jco.2024.42.16_suppl.4591}},

 volume = {{42}},

 journal = {{Journal of Clinical Oncology}},

 issue = {{16_suppl}},

 pages = {{4591-4591}},

 note = {{Accessed on 2025/12/05}}}